Synthesis and antitumor activity of new d-seco and d-homo androstane derivatives

Starting from 3β-hydroxy-17-oxo-16,17-secoandrost-5-ene-16-nitrile ( 1), the new 16,17-secoandrostane derivatives 4– 9 were synthesized. On the other hand, 3β-hydroxy-17-oxa- d-homoandrost-5-ene-16-one ( 10) yielded the new d-homo derivatives 12, 13 and 15. In vitro antiproliferative activity of sel...

Full description

Saved in:
Bibliographic Details
Published inSteroids Vol. 74; no. 12; pp. 983 - 988
Main Authors Djurendic, Evgenija A., Zavis, Marina P., Sakac, Marija N., Canadi, Janos J., Kojic, Vesna V., Bogdanovic, Gordana M., Gasi, Katarina M. Penov
Format Journal Article
LanguageEnglish
Published NEW YORK Elsevier Inc 04.11.2009
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Starting from 3β-hydroxy-17-oxo-16,17-secoandrost-5-ene-16-nitrile ( 1), the new 16,17-secoandrostane derivatives 4– 9 were synthesized. On the other hand, 3β-hydroxy-17-oxa- d-homoandrost-5-ene-16-one ( 10) yielded the new d-homo derivatives 12, 13 and 15. In vitro antiproliferative activity of selected compounds against three tumor cell lines (human breast adenocarcinoma ER+, MCF-7, human breast adenocarcinoma ER−, MDA-MB-231, prostate cancer AR−, PC-3, and normal fetal lung fibroblasts, MRC-5) was evaluated. Compounds 3 and 12 showed strong antiproliferative activity against PC-3 cells, the IC 50 values being 2 μM and 0.55 μM, respectively. Compounds 6 (10 μM) and 14 (9 μM) showed moderate activity against MDA-MB-231 cells. The synthesized compounds 1– 3, 5– 8, 10 and 12– 15 were not toxic to normal fetal lung fibroblasts cells, MRC-5.
ISSN:0039-128X
1878-5867
DOI:10.1016/j.steroids.2009.07.007